Regulation of innate immunity signaling and its connection with human diseases.
Human innate immunity can respond to diverse microbial products, as well as other substances such as heat shock proteins, taxol, and unsaturated fatty acids. Mediated largely by a family of Toll-like-receptors (TLR) and associated intracellular downstream signaling molecules, human innate immune response serves multiple functions ranging from providing the first line of defense to coordinating cellular growth as well as other cellular functions. To date, about 10 distinct human TLR receptors have been identified in the human genome. Biochemical studies and genetic analyses using transgenic mice have revealed specific ligands for several TLR receptors. TLR intracellular domains could then specifically recruit several adaptor proteins including MyD88, TIRAP/MAL, TRIF, and TOLLIP. These adaptor proteins subsequently associate with a family of interleukin-1 receptor-associated kinases (IRAK1, 2, M, and 4). Recruitments of numerous downstream signaling proteins lead to activation of a range of transcription factors such as NF kappa B, AP-1, and IRFs, which are responsible for specific gene transcriptions. Human innate immunity is manifested in diverse cells and tissues. Well-coordinated innate immunity signaling enables human cells and tissues to properly respond to various substances. Improper regulations of such event have been shown to cause various diseases including asthma, atherosclerosis, and cancer. TLR receptors as well as other intracellular signaling proteins can potentially serve as therapeutic targets for numerous human diseases. This review will discuss at the molecular level, regulation of innate immunity signaling as well as its intricate connection with human diseases.
Li
Liwu
L
Department of Medicine, Wake Forest University School of Medicine, Winston Salem, NC27157, USA. lwli@wfubmc.edu
D000818:Animals; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects / Q000502:physiology*; D008024:Ligands; D008562:Membrane Glycoproteins / Q000187:drug effects / Q000502:physiology; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000502:physiology; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D051193:Toll-Like Receptors
D008024:Ligands; D008562:Membrane Glycoproteins; D011956:Receptors, Cell Surface; D051193:Toll-Like Receptors